Anti-enterovirus 71 effects of chrysin and its phosphate ester

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wang, Jianmin ^a   Zhang, Ting ^a   Du, Jiang ^a   Cui, Sheng ^a   Yang, Fan ^a   Jin, Qi ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CHRYSIN; DIISOPROPYL CHRYSIN 7 YL PHOSPHATE; ORGANOPHOSPHATE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; 3C PROTEASES; ANTIVIRUS AGENT; CHRYSENE DERIVATIVE; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; DIISOPROPYL CHRYSIN-7-YL PHOSPHATE; FLAVONOID;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; ENTEROVIRUS 71; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEINASE INHIBITION; VIRION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; ENTEROVIRUS; HUMAN; MOLECULAR DOCKING; PHYSIOLOGY; TUMOR CELL LINE;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHRYSENES; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DRUG EVALUATION, PRECLINICAL; ENTEROVIRUS A, HUMAN; FLAVONOIDS; HUMANS; MOLECULAR DOCKING SIMULATION; ORGANOPHOSPHATES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84897140633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089668     Document Type: Article

References (44)

1. Liao HT, Hung KL (2001) Neurologic involvement in an outbreak of enterovirus 71 infection: a hospital-based study. Acta Paediatr Taiwan 42: 27-32.
2. McMinn P, Stratov I, Nagarajan L, Davis S (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32: 236-242. (Pubitemid 32524793)
3. Li L, He Y, Yang H, Zhu J, Xu X, et al. (2005) Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 43: 3835-3839. (Pubitemid 41129670)
4. Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, et al. (2007) Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 356: 1226-1234. (Pubitemid 46465598)
5. Chu PY, Lin KH, Hwang KP, Chou LC, Wang CF, et al. (2001) Molecular epidemiology of enterovirus 71 in Taiwan. Arch Virol 146: 589-600. (Pubitemid 32258320)
6. McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, et al. (2001) Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 75: 7732-7738. (Pubitemid 32738033)
7. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, et al. (1999) Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis 52: 12-15. (Pubitemid 29414613)
8. Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, et al. (2002) Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 46: 621-627.
9. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351-2352.
10. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, et al. (2009) Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15: 794-797.
11. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, et al. (2009) Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15: 798-801.
12. Tan CW, Poh CL, Sam I-C, Chan YF (2013) Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87: 611-620.
13. Hwang YC, Chen W, Yates MV (2006) Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo. Appl Environ Microbiol 72: 3710-3715. (Pubitemid 43728029)
14. Hu YC, Hsu JT, Huang JH, Ho MS, Ho YC (2003) Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol Lett 25: 919-925. (Pubitemid 36796909)
15. Cui S, Wang J, Fan T, Qin B, Guo L, et al. (2011) Crystal structure of human enterovirus 71 3C protease. J Mol Biol 408: 449-461.
16. Parsley TB, Towner JS, Blyn LB, Ehrenfeld E, Semler BL (1997) Poly (rC) binding protein 2 forms a ternary complex with the 5′-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA 3: 1124-1134.
17. Harris KS, Reddigari SR, Nicklin MJ, Hammerle T, Wimmer E (1992) Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase. J Virol 66: 7481-7489.
18. Weng KF, Li ML, Hung CT, Shih SR (2009) Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog 5: e1000593.
19. Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, et al. (2002) The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293: 386-395.
20. Lei X, Sun Z, Liu X, Jin Q, He B, et al. (2011) Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol 85: 8811-8818.
21. Lei X, Liu X, Ma Y, Sun Z, Yang Y, et al. (2010) The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84: 8051-8061.
22. Lei X, Xiao X, Xue Q, Jin Q, He B, et al. (2013) Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol 87: 1690-1698.
23. Harborne JB, Williams CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55: 481-504.
24. Heim KE, Tagliaferro AR, Bobilya DJ (2002) Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13: 572-584. (Pubitemid 35246546)
25. Lyu SY, Rhim JY, Park WB (2005) Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res 28: 1293-1301.
26. Johari J, Kianmehr A, Mustafa MR, Abubakar S, Zandi K (2012) Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus. Int J Mol Sci 13: 16785-16795.
27. Liu AL, Wang HD, Lee SM, Wang YT, Du GH (2008) Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg Med Chem 16: 7141-7147.
28. Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, et al. (2011) Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J 8: 560.
29. Zhang T, Wu Z, Du J, Hu Y, Liu L, et al. (2012) Anti-Japanese- encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics. PLoS One 7: e30259.
30. Chen XL, Yu ZQ, Qu LB, Yuan JW, Lu JS, et al. (2007) [Phosphorylated modification of genistein and their interaction with lysozyme]. Yao Xue Xue Bao 42: 396-400.
31. Chen XL, Qu LB, Zhang T, Liu HX, Yu F, et al. (2004) The nature of phosphorylated chrysin-protein interactions involved in noncovalent complex formation by electrospray ionization mass spectroscopy. Anal Chem 76: 211-217. (Pubitemid 38040652)
32. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791.
33. Nolan MA, Craig ME, Lahra MM, Rawlinson WD, Prager PC, et al. (2003) Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 60: 1651-1656. (Pubitemid 36618093)
34. Li ZH, Li CM, Ling P, Shen FH, Chen SH, et al. (2008) Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis 197: 854-857. (Pubitemid 351417008)
35. Wang J, Wu Z, Jin Q (2012) COPI is required for enterovirus 71 replication. PLoS One 7: e38035.
36. Hung HC, Chen TC, Fang MY, Yen KJ, Shih SR, et al. (2010) Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother 65: 676-683.
37. Wang J, Du J, Wu Z, Jin Q (2013) Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites. PLoS One 8: e52954.
38. Fernandez M, Caballero J, Helguera AM, Castro EA, Gonzalez MP (2005) Quantitative structure-activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds. Bioorg Med Chem 13: 3269-3277. (Pubitemid 40462128)
39. Mercader AG, Duchowicz PR, Fernandez FM, Castro EA, Bennardi DO, et al. (2008) QSAR prediction of inhibition of aldose reductase for flavonoids. Bioorg Med Chem 16: 7470-7476.
40. Jung HA, Moon HE, Oh SH, Kim BW, Sohn HS, et al. (2012) Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors. Chem Biol Interact 197: 110-118.
41. Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75: 311-335.
42. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27: 493.
43. Malich G, Markovic B, Winder C (1997) The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 124: 179-192. (Pubitemid 28055528)
44. Kuo CJ, Shie JJ, Fang JM, Yen GR, Hsu JT, et al. (2008) Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem 16: 7388-7398.